FOR RELATIONSHIP OF HORMONES TO BONE DENSITY, OSTEOPOROSIS AND BREAST CANCER
There is a hormone relationship to bone mineral density which is the purpose of the saliva test. There has been shown in current literature a relationship between high bone density as a response to an increase in sensitivity to the hormone estradiol. This is also the hormone that is found to be responsive many breast cancers.
A low progesterone value is expected at the typical age of mammography patients because this hormone stops producing at the 35 year old range. This hormone should be supplemented with a natural, not synthetic replacement. Progesterone serves several important functions and therefore replacement should be given careful consideration. Progesterone promotes the development of osteoblasts. This will improve bone mineralization (i.e.: bone density). Progesterone opposes the oncogene for breast cancer which is an important component for breast cancer reduction.
Once the patient has a saliva test for evaluation of the basic hormones, the results are reviewed with a full explanation of the oncogenic and bone mineralization relationships to the hormones.
There is a hormone relationship to bone mineral density which is one reason for obtaining the saliva test. A progesterone value that is low is a common finding and is expected as this hormone stops producing at the 35 year old range. This hormone should be supplemented with a natural, not synthetic replacement. Progesterone serves several important functions and therefore replacement should be given careful consideration. Progesterone promotes the development of osteoblasts. This will improve bone mineralization i.e.: bone density. The abnormally high BMD score indicates“sensitivity” to the hormone estradiol. This also must be treated by balancing the hormone estradiol (an oncogenic accelerator) with progesterone (the oncogenic decelerator).
|
